Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
Clinical trial NCT07350577 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07350577
- Sponsor
- AltruBio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-17
- Primary completion
- 2026-09-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.